Are left axillary lymph nodes measuring 1.22 cm in the long axis and 0.75 cm in the short axis clinically significant or concerning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Assessment of Left Axillary Lymph Nodes

These lymph nodes warrant further evaluation with ultrasound and possible biopsy, as the short-axis measurement of 0.75 cm approaches the threshold for concern, particularly when combined with morphologic features on imaging.

Key Size Thresholds and Clinical Significance

The lymph nodes you describe fall into a borderline category that requires careful assessment:

  • Short-axis diameter >1 cm is associated with increased likelihood of malignancy 1
  • Cortical thickness >0.3 cm is another concerning feature 1
  • Your nodes measure 0.75 cm in short axis, which is below the 1 cm threshold but still warrants attention 1

Critical Morphologic Features to Assess

The most important predictor of malignancy is the absence of a fatty hilum, which has the highest positive predictive value (90%-93%) for malignancy 1. Additional concerning features include:

  • Short-axis to long-axis ratio >0.6 suggests abnormal morphology 2
  • Round or irregular shape rather than oval 3
  • Increased node density 3
  • Eccentric cortical hypertrophy 4

Clinical Context Matters

The significance of these nodes depends heavily on clinical context:

If there is known or suspected breast cancer:

  • Ultrasound-guided biopsy is indicated for any suspicious node, as positive axillary findings help identify patients at risk for higher tumor burden 1
  • Core needle biopsy is superior to fine needle aspiration, with sensitivity of 88% versus 74% 1
  • Even with negative imaging, up to 10% of lymph nodes <5 mm can harbor metastases 5

If presenting as isolated finding:

  • Abnormal axillary lymph nodes without accompanying breast lesion are rare (0.4 per 1000 screened) but may harbor significant pathology 3
  • Differential includes metastatic breast cancer, lymphoma, melanoma, tuberculosis, or benign reactive changes 3

Important Limitations of Size Criteria

A critical pitfall: lymph node size alone is an unreliable predictor of metastatic involvement 5, 6:

  • Lymph nodes <5 mm still have 10% probability of metastatic involvement 5
  • Enlarged nodes (5-20 mm) have only 20% risk of malignancy 5
  • Even nodes >20 mm have only 40% probability of metastatic involvement 5
  • Clinical examination has only 30% sensitivity for detecting axillary metastases 6

Recommended Approach

Proceed with dedicated axillary ultrasound to evaluate:

  • Presence or absence of fatty hilum 1
  • Cortical thickness measurement 1
  • Short-axis to long-axis ratio 2
  • Overall morphology and any suspicious features 1

If any suspicious features are present on ultrasound, ultrasound-guided core needle biopsy should be performed 1, as imaging alone has insufficient negative predictive value to rule out nodal disease 1.

Common Pitfalls to Avoid

  • Do not rely solely on size criteria—morphology is more predictive 1, 5
  • Do not assume normal size excludes malignancy—clinical examination has 93% specificity but only 30% sensitivity 6
  • Do not use mammography alone to evaluate axillary nodes—it has high false-negative rates 1
  • Remember that negative ultrasound does not rule out nodal disease 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.